Insiders FF EAI Robotics Ecosystem Inc.

Stocks

FFR

US74754R3012

Industrial Machinery & Equipment

Market Closed - Nasdaq 16:00:00 2026-10-02 EDT			5-day change	1st Jan Change
1.230 ^USD	+0.82%		-28.90%	-47.44%

08-27	AIxCrypto Holdings, Inc. Secures One-Year USD 33,000 Robot Rental Order And Expands Signed FFAI Robot Order To 23 Units	CI
08-26	AIxCrypto Holdings, Inc. Elects Jason E. Dodier as A Director, Effective August 24, 2026	CI

Insiders

08-26	AIxCrypto Holdings, Inc. Elects Jason E. Dodier as A Director, Effective August 24, 2026	CI
05-28	Aixcrypto Holdings, Inc. Announces CFO Changes	CI
05-28	Aixcrypto Holdings, Inc. Announces Resignation of Kevin Richardson II as Co-Chief Executive Officer of the Company, Effective May 21, 2026	CI
05-28	Aixcrypto Holdings, Inc. Announces Management Changes	CI
12-15	AIxCrypto Inc. Appoints Andrew Grossman As Head Of Legal, Effective December 14, 2025	CI
11-20	Qualigen Therapeutics, Inc Announces Board Ad Committee Changes ,Effective November 17, 2025	CI
25-10-07	Qualigen Therapeutics, Inc. Announces Board and Committee Changes	CI
25-10-06	Qualigen Therapeutics appoints Jerry Wang as co-CEO, Koti Meka as CFO	RE
25-09-30	Qualigen Therapeutics, Inc. Appoints Jerry Wang as Co-Chief Executive Officer, Effective October 2, 2025	CI
25-09-29	Qualigen Therapeutics, Inc. Appoints Kevi Chen as an Independent Member of the Board, Effective September 26, 2025	CI
25-06-24	Qualigen Therapeutics, Inc. Appoints Robert B. Lim to Serve as Chair of the Audit Committee of the Board	CI
25-03-05	Certain Options of Qualigen Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 6-MAR-2025.	CI
24-11-13	Qualigen Therapeutics, Inc. Appoints Graydon Bensler as an Independent Member	CI
24-10-09	Qualigen Therapeutics, Inc. Announces Board and Committee Changes	CI
24-09-26	Qualigen Therapeutics, Inc. Announces Chief Executive Officer Changes	CI
24-09-26	Qualigen Therapeutics, Inc. Announces Management Changes	CI
24-09-26	Qualigen Therapeutics, Inc. Announces Chief Financial Officer Changes	CI
24-07-15	Qualigen Therapeutics, Inc. Announces Board Changes	CI
23-06-26	Qualigen Therapeutics, Inc. Announces Resignation of Amy Broidrick as President, Chief Strategy and Operating Officer and Director	CI
23-05-19	Qualigen Therapeutics, Inc. Announces the Resignation of Amy Broidrick as President, Chief Strategy and Operating Officer and A Director, Effective June 16, 2023	CI
23-01-20	Qualigen Therapeutics, Inc. Announces Executive Changes	CI
22-08-18	Qualigen Therapeutics Inc. Announces Formation and First Meeting of QN-302 Scientific Advisory Board	CI
22-08-18	Qualigen Therapeutics, Inc. Announces Formation and First Meeting of QN-302 Scientific Advisory Board	CI
22-04-29	Qualigen Therapeutics Appoints Shishir Sinha to Lead Diagnostics Division Following Promotion to Senior Vice President	CI
22-02-01	Qualigen Therapeutics Engages Professor Stephen Neidle as Scientific Advisor in the Development of Lead Program QN-302	CI